Axogen Statistics

Total Valuation

Axogen has a market cap or net worth of GBP 644.73 million. The enterprise value is 682.36 million.

Market Cap	644.73M
Enterprise Value	682.36M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.82%
Shares Change (QoQ)	+0.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	38.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 262.75, with an EV/FCF ratio of -110.12.

EV / Earnings	-63.92
EV / Sales	4.69
EV / EBITDA	262.75
EV / EBIT	n/a
EV / FCF	-110.12

Financial Position

The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.72.

Current Ratio	3.74
Quick Ratio	2.13
Debt / Equity	0.72
Debt / EBITDA	22.09
Debt / FCF	-8.59
Interest Coverage	-1.03

Financial Efficiency

Return on equity (ROE) is -14.51% and return on invested capital (ROIC) is -3.13%.

Return on Equity (ROE)	-14.51%
Return on Assets (ROA)	-2.75%
Return on Invested Capital (ROIC)	-3.13%
Return on Capital Employed (ROCE)	-5.03%
Revenue Per Employee	316,009
Profits Per Employee	-24,999
Employee Count	428
Asset Turnover	0.94
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +92.31% in the last 52 weeks. The beta is 0.76, so Axogen's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+92.31%
50-Day Moving Average	15.71
200-Day Moving Average	11.40
Relative Strength Index (RSI)	59.58
Average Volume (20 Days)	1,654

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.88

Income Statement

In the last 12 months, Axogen had revenue of GBP 134.94 million and -10.67 million in losses. Loss per share was -0.25.

Revenue	134.94M
Gross Profit	106.27M
Operating Income	-6.34M
Pretax Income	-10.67M
Net Income	-10.67M
EBITDA	-1.38M
EBIT	-6.34M
Loss Per Share	-0.25

Full Income Statement

Balance Sheet

The company has 18.30 million in cash and 53.20 million in debt, giving a net cash position of -34.90 million.

Cash & Cash Equivalents	18.30M
Total Debt	53.20M
Net Cash	-34.90M
Net Cash Per Share	n/a
Equity (Book Value)	74.17M
Book Value Per Share	1.69
Working Capital	47.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.29 million and capital expenditures -2.91 million, giving a free cash flow of -6.20 million.

Operating Cash Flow	-3.29M
Capital Expenditures	-2.91M
Free Cash Flow	-6.20M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 78.75%, with operating and profit margins of -4.70% and -7.91%.

Gross Margin	78.75%
Operating Margin	-4.70%
Pretax Margin	-7.91%
Profit Margin	-7.91%
EBITDA Margin	-1.02%
EBIT Margin	-4.70%
FCF Margin	n/a

Dividends & Yields

Axogen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.82%
Shareholder Yield	-1.82%
Earnings Yield	-1.66%
FCF Yield	-0.96%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Axogen has an Altman Z-Score of 1.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.35
Piotroski F-Score	n/a